Robot-Assisted surgery for pelvic organ prolapse shows promise in small study
NCT ID NCT07031050
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested the safety and effectiveness of a new robotic system (Dexter) for repairing pelvic organ prolapse in 35 women. The surgery aimed to restore support to the pelvic organs using a robot-assisted approach. The main goals were to see if the procedure could be completed without switching to open or standard laparoscopic surgery, and to track any serious complications within the first six weeks after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexter robotic surgery system
- What this could lead to
- If successful, this could confirm that the Dexter robotic system is a safe and effective tool for performing pelvic organ prolapse surgery.
- What could go wrong
- This is a small, completed observational study with only 35 participants and no comparison group. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
35 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Jan 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients undergoing a sacrocolpopexy or sacrocervicopexy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged \> 18 years * Women with symptomatic stage I or greater pelvic organ prolapse (POP-Q) * Patient agrees to perform the 6-week follow-up assessment as per Standard of Care Exclusion Criteria: * Any planned non-urogynaecological concomitant procedures * History of previous POP surgery, with the exception of transvaginal approaches without mesh implantation * Previous surgery and/or radiation for urologic, gastrointestinal or gynecologic cancer * History of Crohn's disease * Chronic colitis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, Germany
-
Inselspital Bern
Bern, Switzerland
-
Krankenhaus St. Elisabeth
Damme, Germany
-
Spitäler FMI AG
Interlaken, Switzerland
-
Universitätsklinikum Bonn
Bonn, Germany
-
Universitätsmedizin Essen
Essen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can strength training steady the walk and strengthen the pelvic floor after menopause?
- Can a biological mesh improve pelvic floor surgery?
- Can targeted exercises ease mild pelvic organ prolapse without surgery?
- AI may predict which pelvic floor therapy works best
- Can a small pressure drop make prolapse surgery less painful?
- Could a simple surgical step make hysterectomies safer?